UBS Maintains Neutral on GE HealthCare Techs, Raises Price Target to $73
GE Healthcare Technologies Inc.
GE Healthcare Technologies Inc. GEHC | 0.00 |
UBS analyst Graham Doyle maintains GE HealthCare Techs (NASDAQ:
GEHC) with a Neutral and raises the price target from $67 to $73.
